Clinical trials: Late Acquired Stent Malaposition
Late Acquired Stent Malaposition
Late Acquired Malaposition and Different Polymers
The polymers releasing the drug of first-generation drug-eluting stents (DES) may induce allergic reactions and inflammation, resulting in late-acquired stent malaposition (LASM) with uncoverage of struts, and risk of stent…
- Trial name
- NCT02018991
- Testing
- Everolimus-Eluting Stent (EES), Zotarolimus-Eluting-Stent (ZES), Biolimus-Eluting-Stent (BES)
- Where
- Austria
- Volunteers
- 69 people
- Sponsor
- Medical University of Vienna